Lataa...
Preprogrammed long-term systemic pulsatile delivery of parathyroid hormone to strengthen bone
Parathyroid hormone (PTH) is the only FDA approved anabolic agent for the treatment of osteoporosis. The anabolic action of PTH depends on the mode of PTH adminstration. Pulsatile administration promotes bone formation, however continuous PTH exposure results in bone resorption. In addition, the the...
Tallennettuna:
| Julkaisussa: | Adv Healthc Mater |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5299037/ https://ncbi.nlm.nih.gov/pubmed/27930873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.201600901 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|